HOME >> MEDICINE >> NEWS
Study assessing once daily Abacavir (ABC) in a once daily ART regimen

Chicago, Sept. 16, 2003 Studies supporting the efficacy of a once daily (QD) antiretroviral (ART) therapy regimen and the QD dosing of Ziagen (abacavir sulfate) (ABC) were presented here today at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).

CNA30021 Studies QD Regimen

A multicenter, randomized study of HIV-infected ART nave adults compared the virologic response of 600mg QD and 300mg twice daily (BID) regimens of abacavir (in a double-blind manner), each in combination with open-label Epivir (lamivudine) (3TC) 300mg QD and efavirenz (EFV) 600mg QD.

The ABC QD dosing regimen provided an antiretroviral response over 48 weeks that was shown to be non-inferior to the approved ABC BID dosing regimen, according to study results.

"There are a number of antiretroviral drugs that have now received FDA approval to be dosed once a day, but because of drug interactions or food requirements, finding a combination that is 'truly' QD with a patient taking all his ART medications at one time, once a day has been daunting," said Doug Manion, M.D., GSK vice president of clinical development. "It has been GSK's goal to test our established drugs to determine if the data would support their use QD, providing greater flexibility for patients and physicians. Epivir is already approved to be dosed once a day and the data from the two studies being presented at ICAAC this week provide additional insight into QD dosing of Ziagen. If you add in efavirenz, which is also given once daily, a true QD regimen appears possible with patients being able to take three ART pills once a day."

In the study of 770 individuals, 66 percent in the ABC QD group versus 68 percent in the ABC BID group achieved and maintained plasma HIV-1 RNA of <50 copies/mL through 48 weeks. Virologic failure was infrequent and similar between the treatment groups (10 percent in the QD group versus 8 percent in the BID group). Patients at basel
'"/>

Contact: Elaine Salewske
esalewske@pcipr.com
312-558-1770
Public Communications Inc.
16-Sep-2003


Page: 1 2 3 4 5

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/15/2019)... ... 15, 2019 , ... Esteemed Marietta dentist Dr. Michael Mansouri is pleased to ... private dental assistant school is recognized as one of the best Dental Assisting programs ... days of graduation. Assisting 101 - School of Dental Assisting offers both online and ...
(Date:3/14/2019)... (PRWEB) , ... March 14, 2019 , ... The ... Friday, March 15th at the Bellevue Club in Bellevue, Washington. GBM is short for ... EBCI and its sponsors and partners invite current and past brain cancer patients, survivors, ...
(Date:3/14/2019)... ... March 13, 2019 , ... NuView Life Sciences (NVLS) ... conducted by Intermountain Healthcare of its proprietary in vitro prostate cancer urine test ... NVDx is a pre-revenue oncology company that is focused on developing and commercializing ...
(Date:3/12/2019)... ... March 12, 2019 , ... As the Official ... will provide comprehensive, on-site services at the exclusive Midway medical center for the ... The Infield Care Center will be staffed with emergency physicians and nurses who ...
(Date:3/12/2019)... ... March 12, 2019 , ... Caring Transitions is pleased to ... nation. The business is owned by mother/daughter team Donna and Nicole Rea with the ... by mother and daughter Donna and Nicole of Caring Transitions of North Dallas Suburbs ...
Breaking Medicine News(10 mins):
(Date:3/13/2019)... DALLAS (PRWEB) , ... March 13, 2019 , ... Not all CBD oils are created ... organically grown and full spectrum. Using the most advanced nano technology, the absorption rate and ... compliant. , Stay Young brand Hemp CBD is gluten free and contains no harsh ...
(Date:3/12/2019)... ... ... The nation's top provider of stem cell training courses , R3 ... for obtaining the discount is R3SCT500. , R3 Stem Cell is the nation’s leader ... year, R3 began its first stem cell therapy training courses, teaching providers how to ...
(Date:3/12/2019)... ... March 12, 2019 , ... ... Management, and nCipher (previously Thales) for Hardware Security - Niagara Health (NH) is ... Navigator. The mobile application is Ontario’s first digital health ecosystem designed to protect ...
Breaking Medicine Technology:
Cached News: